Most recent update: Friday, January 24, 2020 - 11:27

Bariatric News - Cookies & privacy policy

You are here

gastric banding

23-years study indicates banding has long lasting beneficial effects

The preventive effect of gastric banding (GB) on mortality is maintained up to 23 years, according to researcher from Milan, Italy. However, the preventive effect of GB on co-morbidities and on hospital admissions increases with time.

LSG betters banding for food tolerance and eating disorders

Laparoscopic sleeve gastrectomy (LSG) patients had superior outcomes in both food tolerance and eating disorder behaviours, compared with laparoscopic banding, according to researchers from Bahrain Defence Force Hospital, Riffa, Bahrain. However, despite these differences, the quality of life (QoL) did not significantly differ between the sleeve and gastric banding groups.

Revisional surgery more common after banding and VBG than GBP

Patients who underwent gastric banding and vertical banded gastroplasty (VBG) have much higher rates of revisional surgery, according to the 26-year follow-up from the Swedish Obese Subjects (SOS) study. Overall, the incidence rates were 40.7% in the banding subgroup, 28.3% in the VBG subgroup and 7.5% in the gastric bypass (GBP) subgroup.

Gastric banding more effective than metformin in treating T2DM

People with prediabetes or new-onset type 2 diabetes who had gastric banding had similar stabilisation of their disease to those who took metformin alone, according to a study supported by the National Institutes of Health.

Gastric banding and IMWM offer similar benefits

A small clinical trial among such patients led by Joslin Diabetes Center and Brigham and Women's Hospital researchers now has shown that two approaches - adjustable gastric band (LAGB) surgery and an intensive group-based medical diabetes and weight management programme (IMWM) - achieved similar improvements in controlling blood sugar levels after one year.

Nutrition: VLCD and RYGB have opposite effects

Calorie restriction and Roux-en-Y Gastric bypass surgery (RYGB) have opposite effects on serum bile salt and Fibroblast growth factors (FGF) 21 levels, according to a study that examined the effect of different weight loss strategies on levels of the metabolic regulator FGF21 in morbidly obese females with normal glucose tolerance (NGT) or type 2 diabetes mellitus (T2DM).

RYGB has more complications, greater weightloss vs. AGB

Gastric bypass surgery runs a higher risk of short-term complications compared with patients who underwent gastric banding, although bypass patients did experience greater weight loss, according to a study published in JAMA Surgery.

RYBG has better weight loss, more complications

In a study comparing laparoscopic Roux-en-Y gastric bypass (RYGB) and adjustable gastric banding (AGB), bypass resulted in much greater weight loss than but had a higher risk of short-term complications and long-term subsequent hospitalisations, according to a report published online by JAMA Surgery.

Bypass betters banding for controlling chronic conditions

Gastric bypass surgery has better outcomes than gastric banding for long-term weight loss, controlling type 2 diabetes and high blood pressure, and lowering cholesterol levels, according to a review by UT Southwestern Medical Center surgeons of nearly 30 long-term studies comparing the two types of bariatric procedures.

Bone loss associated with sleeve but not banding

A comparison of different modalities of bone loss has reported that patients undergoing laparoscopic sleeve gastrectomy had reduced bone, compared with patients who underwent gastric banding. The study, presented at ENDO2013, the annual meeting of the Endocrine Society, in San Francisco, concluded that bone loss associated with sleeve patients was not accounted for by weight loss alone, and may involve changes in factors such as Peptide YY and adiponectin.

Subscribe to RSS - gastric banding